T2 Biosystems

T2 Biosystems Dividend Coverage

Dividend Coverage Ratio of T2 Biosystems (TTOO) as of Oct 19, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of T2 Biosystems is 2026 - . Dividend Coverage Ratio of T2 Biosystems was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

T2 Biosystems Stock analysis

What does T2 Biosystems do? T2 Biosystems Inc, headquartered in Lexington, Massachusetts, operates in the Health Care sector, specifically within Biotechnology. The company develops the T2 Magnetic Resonance platform (T2MR), which detects pathogens, biomarkers, and abnormalities in unpurified patient samples like whole blood and urine. Its technology enables detection at one colony forming unit per milliliter (CFU/mL) and targets sepsis, hemostasis, and Lyme disease. T2 Biosystems offers the T2Dx Instrument and T2Candida Panel for diagnostic use. T2 Biosystems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about T2 Biosystems stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio T2 Biosystems since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's T2 Biosystems historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — T2 Biosystems

All Key Metrics — T2 Biosystems